SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : IDPH--Positive preliminary results for pivotal trial of ID

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: guido leone who wrote (730)4/20/1997 6:51:00 PM
From: I. Luttichuys   of 1762
 
Hello guido, This is very comforting to hear. Most of us have been faithful to IDEC and SBC Warburg's statements that nothing is wrong with the company or it's trials. It is easy to be fearful in a situation where so many sales have occured but, I think many of us knew such a thing was potentially coming many months ago with Merril Lynch and Morgan Stanley in possession of the convertable. The motivation for the Smith Kline sales have been troublesome to many. Very ugly to see the stock perform this way as a result but, I am playing this exactly as I did last summer when IDEC fell to 13 7/8 from 32 5/8. I would not be surprised to have an equally favourable outcome if Mr. Murphy is correct. My actions in accumulating so far have simply been in trust that everything is well as IDEC has stated it is. I have bought at both 16 and 18 1/8.
This may be a very welcome opportunity...
Thank you for posting,
BENNETT
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext